https://sputnikglobe.com/20210712/sputnik-v-covid-19-vaccine-effective-against-new-coronavirus-variants-developers-say-1083373576.html
Sputnik V COVID-19 Vaccine Effective Against New Coronavirus Variants, Developers Say
Sputnik V COVID-19 Vaccine Effective Against New Coronavirus Variants, Developers Say
Sputnik International
MOSCOW (Sputnik) - Russia’s Sputnik V COVID-19 vaccine is effective against new coronavirus variant, developer Gamaleya Research Centre and the Russian Direct... 12.07.2021, Sputnik International
2021-07-12T13:20+0000
2021-07-12T13:20+0000
2021-07-13T06:55+0000
russia
world
newsfeed
coronavirus
covid-19
sputnik v vaccine
vaccine
russia
russian direct investment fund (rdif)
https://cdn1.img.sputnikglobe.com/img/07e5/07/08/1083333351_0:160:3073:1888_1920x0_80_0_0_8f137779176dc6019a7992a000bebaff.jpg
"Vaccination with Sputnik V has produced protective neutralising titers against new variants, including Alpha B.1.1.7 (first identified in the UK), Beta B.1.351 (first identified in South Africa), Gamma P.1 (first identified in Brazil), Delta B.1.617.2 and B.1.617.3 (first identified in India) and Moscow endemic variants B.1.1.141 and B.1.1.317", the Gamaleya Centre and RDIF said in a press release. Back in August 2020, Sputnik V became the world’s first officially registered vaccine against the novel coronavirus. It has since been approved in 67 countries worldwide, and its efficacy is estimated to be at 97.6%, according to an analysis of data on vaccinated Russians.
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2021
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/07e5/07/08/1083333351_170:0:2901:2048_1920x0_80_0_0_b2b55f4f24f8df3e6070e018486147de.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, coronavirus, covid-19, sputnik v vaccine, vaccine, russia, russian direct investment fund (rdif)
newsfeed, coronavirus, covid-19, sputnik v vaccine, vaccine, russia, russian direct investment fund (rdif)
Sputnik V COVID-19 Vaccine Effective Against New Coronavirus Variants, Developers Say
13:20 GMT 12.07.2021 (Updated: 06:55 GMT 13.07.2021) MOSCOW (Sputnik) - Russia’s Sputnik V COVID-19 vaccine is effective against new coronavirus variant, developer Gamaleya Research Centre and the Russian Direct Investment Fund (RDIF) said on Monday.
"Vaccination with Sputnik V has produced protective neutralising titers against new variants, including Alpha B.1.1.7 (first identified in the UK), Beta B.1.351 (first identified in South Africa), Gamma P.1 (first identified in Brazil), Delta B.1.617.2 and B.1.617.3 (first identified in India) and Moscow endemic variants B.1.1.141 and B.1.1.317", the Gamaleya Centre and RDIF said in a press release. Back in August 2020, Sputnik V became the world’s first officially registered vaccine against the novel coronavirus. It has since been approved in 67 countries worldwide, and its efficacy is estimated to be at 97.6%, according to an analysis of data on vaccinated Russians.